A Strep Throat Controlled Human Infection Trial in Healthy Adults

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 24, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

June 30, 2027

Conditions
Streptococcus Pyogenes PharyngitisStreptococcus Infection
Interventions
BIOLOGICAL

Streptococcus pyogenes M1UK strain MCRI0102

Human challenge with S. pyogenes M1UK strain MCRI0102

Trial Locations (1)

3002

RECRUITING

Doherty Clinical Trials Ltd, Melbourne

All Listed Sponsors
collaborator

University of Auckland, New Zealand

OTHER

collaborator

University of Melbourne

OTHER

collaborator

University of Wollongong

OTHER

collaborator

Université Libre de Bruxelles

OTHER

collaborator

University of California, San Diego

OTHER

collaborator

Leducq Foundation

OTHER

collaborator

National Health and Medical Research Council, Australia

OTHER

collaborator

Monash University

OTHER

collaborator

Duke University

OTHER

collaborator

The University of Queensland

OTHER

collaborator

Doherty Clinical Trials Ltd

UNKNOWN

lead

Murdoch Childrens Research Institute

OTHER